Indeed, tumor-derived sEVs can stimulate a significant release of various cytokines, including IL-6, TNF, and TGF-β by CD14+ monocytes from healthy donors and can promote suppression of their functions as well as the proliferation of T cells [127]. Here, IL6 is linked to neoplasm.